Page 472 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 472

458     SECTION V  Drugs That Act in the Central Nervous System




                 PREP AR A TIONS A V AIL ABLE                                *


                          GENERIC NAME             AVAILABLE AS                GENERIC NAME             AVAILABLE AS
                 Desflurane                     Suprane               Ketamine                      Generic, Ketalar
                 Dexmedetomidine                Precedex              Lorazepam                     Generic, Ativan
                 Diazepam                       Generic, Valium       Methohexital                  Generic, Brevital
                 Droperidol                     Generic, Inapsine     Midazolam                     Generic, Versed
                 Enflurane                      Enflurane, Ethrane    Nitrous oxide (gas, supplied in blue   Generic
                 Etomidate                      Generic, Amidate      cylinders)
                 Fospropofol                    Lusedra               Propofol                      Generic, Diprivan
                 Halothane                      Generic, Fluothane    Sevoflurane                   Generic, Ultane
                 Isoflurane                     Generic, Forane, Terrell  Thiopental                Pentothal
                 * See Chapter 31 for names of opioid agents used in anesthesia.


                 REFERENCES                                          Hirshey Dirksen SJ et al: Future directions in malignant hyperthermia research and
                                                                         patient care. Anesth Analg 2011;113:1108.
                 Allaert SE et al: First trimester anesthesia exposure and fetal outcome. A review.   Lugli AK, Yost CS, Kindler CH: Anesthetic mechanisms: Update on the challenge
                    Acta Anaesthesiol Belg 2007;58:119.                  of unravelling the mystery of anaesthesia. Eur J Anaesth 2009;26:807.
                 Ebert  TJ et al: Desflurane-mediated sympathetic activation occurs in humans   Olkkola  KT,  Ahonen  J:  Midazolam  and  other  benzodiazepines.  Handb  Exp
                    despite preventing hypotension and baroreceptor unloading. Anesthesiology   Pharmacol 2008;182:335.
                    1998;85:1227.
                 Eger EI II: Uptake and distribution. In: Miller RD (editor): Anesthesia, 7th ed.   Reves JG et al: Intravenous anesthetics. In: Miller RD (editor): Anesthesia, 7th ed.
                                                                         Churchill Livingstone, 2010.
                    Churchill Livingstone, 2010.
                 Eger EI II, Saidman LJ, Brandstater B: Minimum alveolar anesthetic concentra-  Rudolph U et al: Sedatives, anxiolytics, and amnestics. In: Evers AS, Maze M
                                                                         (editors): Anesthetic Pharmacology: Physiologic Principles and Clinical Practice.
                    tion: A standard of anesthetic potency. Anesthesiology 1965;26:756.  Churchill Livingstone, 2004.
                 Fraga M et al: The effects of isoflurane and desflurane on intracranial pressure,   Sjogren D, Lindahl SGE, Sollevi A: Ventilatory responses to acute and sustained
                    cerebral perfusion and cerebral arteriovenous oxygen content difference in   hypoxia during isoflurane anesthesia. Anesth Analg 1998;86:403.
                    normocapnic patients with supratentorial brain tumors. Anesthesiology
                    2003;98:1085.                                    Stoelting R, Hillier S: Barbiturates. In: Stoelting RK, Hillier SC (editors): Pharma-
                 Fragen RJ: Drug Infusions in Anesthesiology. Lippincott Williams & Wilkins, 2005.  cology and Physiology in Anesthetic Practice. Lippincott Williams & Wilkins,
                                                                         2005.
                 Hemmings  HC  et  al:  Emerging  molecular  mechanisms  of  general  anesthetic   Yasuda N et al: Kinetics of desflurane, isoflurane, and halothane in humans.
                    action. Trends Pharmacol Sci 2005;26:503.
                                                                         Anesthesiology 1991;70:489.



                   C ASE  STUD Y  ANSWER

                   This patient presents with significant underlying cardiac   of inhaled agent(s) would be made based on the desire to
                   risk and is scheduled to undergo major stressful surgery.   maintain sufficient myocardial contractility, systemic blood
                   Balanced anesthesia would begin with intravenous agents   pressure, and cardiac output for adequate perfusion of criti-
                   that cause minimal changes in blood pressure and heart rate   cal organs throughout the operation. If the patient’s ischemic
                   such as a lowered dose of propofol or etomidate, combined   pain has been chronic and severe, a low-dose ketamine
                   with potent analgesics such as fentanyl (see Chapter 31) to   infusion may be administered for additional pain control.
                   block undesirable stimulation of autonomic reflexes. Main-  Rapid emergence from the combined effects of the chosen
                   tenance of anesthesia could incorporate inhaled anesthetics   anesthetic drugs, which would facilitate the patient’s return
                   that ensure unconsciousness and amnesia, additional intra-  to a baseline state of heart function, breathing, and menta-
                   venous agents to provide intraoperative and postoperative   tion, can be attained by understanding the known pharma-
                   analgesia, and, if needed, neuromuscular blocking drugs   cokinetic properties of the anesthetic agents as presented in
                   (see Chapter 27) to induce muscle relaxation. The choice   this chapter.
   467   468   469   470   471   472   473   474   475   476   477